It's always difficult when patients hear the news that they have cancer. For many, the diagnosis of Non-Hodgkin's lymphoma is a frightening experience. People with weakened immune systems have a higher risk of developing the condition, but more must be done to understand non-Hodgkin's lymphoma. Researchers are conducting studies to better understand risk factors that involve chemical exposure.
However, people need to remember that they are not alone in this fight. Many others have battled this disease and come out on top, and there are also existing treatments and promising innovations coming down the pipe. One way to combat fear is through knowledge. This article gives a brief introduction to some of the facets of non-hodgkin’s lymphoma in an effort to help people understand it just a little better.
Signs and Symptoms
Non-Hodgkin's lymphoma develops within the lymphatic system. This system is a network of blood vessels and nodes that helps remove toxins and fluids from the body. Non-Hodgkin's lymphoma begins when cells in the lymphatic system grow abnormally. These cancerous cells can spread throughout the entire lymphatic system and eventually to other organs in the body.
There are several types of non-Hodgkin's lymphoma, and each type can cause different symptoms. There are also some general signs which some people may deal with. These are associated with non-hodgkin's lymphoma. These include fatigue, swollen lymph nodes, weight loss, and night sweats. Anyone that experiences one or more of these symptoms should see a doctor to pursue proper diagnosis and treatment.
Understanding the Difference Between Non-Hodgkin's and Hodgkin's Lymphoma
While Hodgkin's and non-Hodgkin's lymphoma share many similarities, some important distinctions exist between the two types of cancer. The most significant difference is the presence of Reed-Sternberg cells in Hodgkin's lymphoma. These cells are large, abnormal white blood cells that are not seen in non-Hodgkin's lymphoma. It should be noted that Reed-Sternberg cells are believed to be critical in the development of Hodgkin's lymphoma.
In addition, Hodgkin's lymphoma is more likely to affect young adults, while non-Hodgkin's lymphoma is more common in older adults. Finally, Hodgkin's lymphoma tends to respond better to treatment than non-Hodgkin's lymphoma. While there is no cure for either type of cancer, patients with Hodgkin's lymphoma have a higher survival rate.
Treatment and Outlook for Non-Hodgkin's Lymphoma
There are two main types of treatment for non-Hodgkin's lymphoma: radiation therapy and chemotherapy. Radiation therapy uses high-energy waves to eliminate cancer cells, while chemotherapy uses drugs get rid of the cancer cells.
The type of treatment that is used depends on the stage of the cancer, the type of cancer and the patient's overall health. The outlook for patients with non-Hodgkin's lymphoma is typically very good. Most patients can be treated successfully, and the majority of patients will go into remission. However, the disease can come back, so it is important for patients to undergo regular follow-up care.
There is currently no known way to prevent non-Hodgkin's lymphoma, but some steps can be taken to reduce the risk, such as avoiding exposure to toxic chemicals and maintaining a healthy lifestyle. In addition, advancements in chemotherapy drugs, immunotherapy and targeted therapies look to improve the outlook for non-Hodgkin's lymphoma patients over the coming years.